Riskpilot← Back to searchSign inGet full accessBellman Fotklinik AB
ABActiveOrg 5591474795Sportfältsvägen 3Physiotherapy activities · NACE 8695Est. 20181 employees
Revenue 2024
SEK 810K
+2% vs 2023
EBITDA margin
4.7%
+8% vs 2023
Equity ratio
94.4%
Financial strength
Net profit 2024
SEK 30K
+8% vs 2023
| Revenue | SEK 810K | +2% |
| EBITDA | SEK 38K | +8% |
| Net profit | SEK 30K | +8% |
| Total assets | SEK 298K | +39% |
| Equity | SEK 281K | +12% |
| Employees | 1 | — |
Legal name
Bellman Fotklinik AB
Org number
5591474795
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
1 februari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att utföra medicinsk fotvård.
Address
Sportfältsvägen 3
Phone
+46701711421
Email
bellmanfotklinik@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 709 | 712 | 718 | 794 | 810 |
| Staff expenses | — | — | — | −555 | −555 |
| EBITDA | 78 | −32 | 22 | 35 | 38 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 78 | −32 | 22 | 35 | 38 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | 208 | 93 | 23 | 36 | 39 |
| Tax | −45 | −19 | −5 | −8 | −8 |
| Net profit | 163 | 74 | 18 | 28 | 30 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 308 | 261 | 183 | 214 | 298 |
| Equity | 231 | 305 | 223 | 251 | 281 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 49 | 44 | 40 | −37 | 17 |
| Total debt | 49 | 44 | 40 | −37 | 17 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20202024
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20202024
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20202024
Asset turnover
2.72×
This company
1.12×
Market median
+143% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (2) | ||
| Board of Directors | 2022 – 2026 | |
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bellman Fotklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sheida Ghassemi | Board of Directors | 0 companies |
| Babak Salimirad | Deputy Board Member | 0 companies |
| Mohammad Sepandian Manesh | Board of Directors | 0 companies |
| Elham Zeinvand | Board of Directors | 0 companies |